100,000 Genomes Project hits half way mark

21 Feb 2018, 4:02 p.m.

The pioneering 100,000 Genomes Project has reached the 50,000 genomes landmark. It’s a milestone that has only been made possible through the generous participation of tens of thousands of patients and their families, including 1,492 GOSH families.The project aims to sequence 100,000 genomes from around 70,000 people to help doctors better understand, and ultimately treat, rare and inherited diseases and various cancers.

Great Ormond Street Hospital (GOSH) leads the North Thames Genomic Medicine Centre, one of 13 regional centres which are responsible for coordinating recruitment of more than 100 patients a month. So far 12,315 genomes have been collected by the North Thames Genomic Medicine Centre including 4,142 genomes collected at GOSH and 1,492 GOSH families recruited.

In 2016 GOSH patients Georgia and Jessica were the first to receive a genetic diagnosis as part of the 100,000 Genomes Project. For patients with rare diseases, a diagnosis can remove a large amount of uncertainty for the families, often after many years of distress. The results can have a major impact on many areas of patient lives including future treatment options, social support and family planning. They also have the potential to help many more children with undiagnosed conditions who may be tested for these genetic mutations early on and be offered a diagnosis to help manage their condition most effectively.

Teenager off to university after life-changing gene therapy

A teenager with a rare, life-limiting genetic condition is off to university after receiving a gene therapy that changed his life.

Stem cell treatment can improve rare skin condition in children

Children with a rare skin condition have found their symptoms have improved through taking part in the largest clinical trial of its kind, led by clinicians at Great Ormond Street Hospital for Children (GOSH).

Young people donate tissue samples to unlock mysteries of arthritis

A new groundbreaking study led by researchers at the University of Birmingham, Great Ormond Street Hospital, University College London and Birmingham Children’s Hospital has revealed important clues into what is driving arthritis in children.

Toddler doing well after receiving newest gene therapy available on NHS

A toddler with a life-limiting and life-threatening rare disease is the youngest to be treated with the newest gene therapy available on the NHS at GOSH.